An experimental gene therapy appeared to dramatically increase the production of a muscle-making protein in three young boys with Duchenne muscular dystrophy, a deadly and irreversible disease, according to results being presented by the drugmaker Sarepta Therapeutics at an investor event.
A Gene Therapy Appears ToReplaceMissing ProteinIn Muscular Dystrophy Patients
